Asthma symptoms in obese adults: The challenge of achieving asthma control
Research output: Contribution to journal › Editorial › Research › peer-review
Standard
Asthma symptoms in obese adults : The challenge of achieving asthma control. / Ulrik, Charlotte Suppli.
In: Expert Review of Clinical Pharmacology, Vol. 9, No. 1, 2016, p. 5-8.Research output: Contribution to journal › Editorial › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Asthma symptoms in obese adults
T2 - The challenge of achieving asthma control
AU - Ulrik, Charlotte Suppli
PY - 2016
Y1 - 2016
N2 - The association between asthma and obesity is well-described, but not straightforward, and according to current guidelines asthma control is more difficult to achieve in obese patients. The currently available studies evaluating response to pharmacological asthma therapy in obese patients show that these patients have an altered, in general less favorable, response to both reliever and controller medication compared to normal weight patients. However, at present, the limited available evidence precludes evidence-based recommendations. The 'obesity-related asthma' phenotype has different characteristics, including association with atopy and type of airway inflammation, compared to 'classic' asthma. Furthermore, weight loss in patients with this phenotype leads to an improvement in symptoms, lung function, and airway responsiveness, as well as a reduction in medication utilization and hospital admissions. Obese patients, who present with symptoms suggesting a diagnosis of asthma, may have a distinct phenotype or a disease mimicking asthma, likely to have a potentially higher remission rate. And by that, our approach to this group of patients should combine pharmacologic and non-pharmacologic therapies, including exercise, weight loss and dietary interventions, instead of primarily focusing on disease control by stepping up asthma therapy.
AB - The association between asthma and obesity is well-described, but not straightforward, and according to current guidelines asthma control is more difficult to achieve in obese patients. The currently available studies evaluating response to pharmacological asthma therapy in obese patients show that these patients have an altered, in general less favorable, response to both reliever and controller medication compared to normal weight patients. However, at present, the limited available evidence precludes evidence-based recommendations. The 'obesity-related asthma' phenotype has different characteristics, including association with atopy and type of airway inflammation, compared to 'classic' asthma. Furthermore, weight loss in patients with this phenotype leads to an improvement in symptoms, lung function, and airway responsiveness, as well as a reduction in medication utilization and hospital admissions. Obese patients, who present with symptoms suggesting a diagnosis of asthma, may have a distinct phenotype or a disease mimicking asthma, likely to have a potentially higher remission rate. And by that, our approach to this group of patients should combine pharmacologic and non-pharmacologic therapies, including exercise, weight loss and dietary interventions, instead of primarily focusing on disease control by stepping up asthma therapy.
U2 - 10.1586/17512433.2016.1093415
DO - 10.1586/17512433.2016.1093415
M3 - Editorial
C2 - 26427601
VL - 9
SP - 5
EP - 8
JO - Expert Review of Clinical Pharmacology
JF - Expert Review of Clinical Pharmacology
SN - 1751-2433
IS - 1
ER -
ID: 162030147